{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:17:40Z","timestamp":1759342660119},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13104-015-1219-4","type":"journal-article","created":{"date-parts":[[2015,6,12]],"date-time":"2015-06-12T13:28:49Z","timestamp":1434115729000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Genetic determinants of cocaine-associated agranulocytosis"],"prefix":"10.1186","volume":"8","author":[{"given":"Jane A","family":"Buxton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Omura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margot","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Despina","family":"Tzemis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy","family":"Purssell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Gardy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Carleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,13]]},"reference":[{"issue":"9","key":"1219_CR1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-146-9-200705010-00009","volume":"146","author":"F Andersohn","year":"2007","unstructured":"Andersohn F, Konzen C, Garbe E (2007) Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med 146(9):657\u2013665","journal-title":"Ann Intern Med"},{"issue":"3","key":"1219_CR2","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1309\/AJCPOPQNBP5THKP1","volume":"133","author":"DR Czuchlewski","year":"2010","unstructured":"Czuchlewski DR, Brackney M, Ewers C, Manna J, Fekrazad MH, Martinez A et al (2010) Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine. Am J Clin Pathol 133(3):466\u2013472","journal-title":"Am J Clin Pathol"},{"key":"1219_CR3","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0268-960X(90)90002-A","volume":"4","author":"AV Pisciotta","year":"1990","unstructured":"Pisciotta AV (1990) Drug induced agranulocytosis peripheral destruction of polymorphonuclear leukocytes and their marrow precursors. Blood Rev 4:226\u2013237","journal-title":"Blood Rev"},{"issue":"3","key":"1219_CR4","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1182\/blood.V56.3.388.388","volume":"56","author":"JS Thompson","year":"1980","unstructured":"Thompson JS, Herbick JM, Klassen LW, Severson CD, Overlin VL, Blaschke JW et al (1980) Studies on levamisole-induced agranulocytosis. Blood 56(3):388\u2013396","journal-title":"Blood"},{"issue":"3","key":"1219_CR5","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/clpt.2010.156","volume":"88","author":"A Chang","year":"2010","unstructured":"Chang A, Osterloh J, Thomas J (2010) Levamisole: a dangerous new cocaine adulterant. Clin Pharmacol Ther 88(3):408\u2013411","journal-title":"Clin Pharmacol Ther"},{"key":"1219_CR6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1477-7517-6-30","volume":"6","author":"L Knowles","year":"2009","unstructured":"Knowles L, Buxton JA, Skuridina N, Achebe I, Legatt D, Fan S et al (2009) Levamisole tainted cocaine causing severe neutropenia in Alberta and British Columbia. Harm Reduct J 6:30","journal-title":"Harm Reduct J"},{"issue":"3\u20134","key":"1219_CR7","first-page":"134","volume":"3","author":"AMM Valentino","year":"2005","unstructured":"Valentino AMM, Fuentecilla K (2005) Levamisole: an analytical profile. Microgram J 3(3\u20134):134\u2013137","journal-title":"Microgram J"},{"key":"1219_CR8","first-page":"1381","volume":"58","author":"Centers for Disease Control and Prevention","year":"2009","unstructured":"Centers for Disease Control and Prevention (2009) Agranulocytosis associated with cocaine use-four states, March 2008\u2013November 2009. Morb Mortal Wkly Rep 58:1381\u20131385","journal-title":"Morb Mortal Wkly Rep"},{"issue":"4","key":"1219_CR9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.7326\/0003-4819-150-4-200902170-00102","volume":"150","author":"NY Zhu","year":"2009","unstructured":"Zhu NY, LeGatt DF, Turner AR (2009) Agranulocytosis after consumption of cocaine adulterated with levamisole. Ann Intern Med 150(4):287\u2013289","journal-title":"Ann Intern Med"},{"issue":"24","key":"1219_CR10","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1056\/NEJMicm1008722","volume":"364","author":"TT Muirhead","year":"2011","unstructured":"Muirhead TT, Eide MJ (2011) Toxic effects of levamisole in a cocaine user. N Engl J Med 364(24):e52","journal-title":"N Engl J Med"},{"key":"1219_CR11","unstructured":"Health TP (2014) Levamisole in crack and powder cocaine; Toronto Public Health, Information for professionals: Toronto Public Health; [cited 2014 January 4]. Available from: http:\/\/www.toronto.ca\/health\/professionals\/communicable_diseases\/levamisole.htm"},{"issue":"11","key":"1219_CR12","doi-asserted-by":"crossref","first-page":"758","DOI":"10.7326\/0003-4819-152-11-201006010-00026","volume":"152","author":"M Bradford","year":"2010","unstructured":"Bradford M, Rosenberg B, Moreno J (2010) Bilateral necrosis of earlobes and cheeks: another complication of cocaine contaminated with levamisole. Ann Intern Med 152(11):758\u2013759","journal-title":"Ann Intern Med"},{"issue":"6","key":"1219_CR13","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.jaad.2013.07.037","volume":"69","author":"L Strazzula","year":"2013","unstructured":"Strazzula L, Brown KK, Brieva JC, Camp BJ, Frankel HC, Kissin E et al (2013) Levamisole toxicity mimicking autoimmune disease. J Am Acad Dermatol 69(6):954\u2013959","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1219_CR14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/15563650.2012.665455","volume":"50","author":"A Larocque","year":"2012","unstructured":"Larocque A, Hoffman RS (2012) Levamisole in cocaine: unexpected news from an old acquaintance. Clin Toxicol (Phila) 50(4):231\u2013241","journal-title":"Clin Toxicol (Phila)"},{"issue":"1","key":"1219_CR15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1503\/cmaj.090286","volume":"182","author":"MO Wiens","year":"2010","unstructured":"Wiens MO, Son WK, Ross R, Hayden M, Carleton B (2010) Cocaine adulterant linked to neutropenia. Can Med Assoc J 182(1):57\u201369","journal-title":"Can Med Assoc J"},{"key":"1219_CR16","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/BF01476864","volume":"56","author":"KL Schmidt","year":"1978","unstructured":"Schmidt KL, Mueller-Eckhardt C, Breithaupt H (1978) HLA-B27, antinuclear antibodies and drug-induced agranulocytosis. Klin Wochenschr 56:1189\u20131191","journal-title":"Klin Wochenschr"},{"issue":"4","key":"1219_CR17","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1159\/000232788","volume":"65","author":"L Hodinka","year":"1981","unstructured":"Hodinka L, Geher P, Meretey K, Gyodi EK, Petranyi GG, Bozsoky S (1981) Levamisole-induced neutropenia and agranulocytosis: association with HLA B27 leukocyte agglutinating and lymphocytotoxic antibodies. Int Arch Allergy Appl Immunol 65(4):460\u2013464 19810915 DCOM- 19810915","journal-title":"Int Arch Allergy Appl Immunol"},{"issue":"2","key":"1219_CR18","first-page":"104","volume":"3","author":"H Mielants","year":"1971","unstructured":"Mielants H, Veys EM (1971) B27 and agranulocytosis in rheumatoid arthritis patients treated with levamisole. Acta Rhumatol 3(2):104\u2013107 20010810 DCOM- 20010830","journal-title":"Acta Rhumatol"},{"key":"1219_CR19","unstructured":"BC Center for Disease Control (2011) Agranulocytosis Associated with Levamisole in Cocaine: BC Center for Disease Control; [updated May 27, 2011; cited 2013 June 1]. Available from: http:\/\/www.bccdc.ca\/prevention\/HarmReduction\/Agranulocytosis+Associated+with+Levamisole+in+Cocaine\/default.htm"},{"issue":"1\u20132","key":"1219_CR20","first-page":"179","volume":"287","author":"S Kuzio","year":"2004","unstructured":"Kuzio S, Hanguehard A, Morelle M, Ronsin C (2004) Rapid screening for HLA-B27 by a TaqMan-PCR assay using sequence-specific primers and a minor groove binder probe, a novel type of TaqMan trade mark probe. J Immunol Methods 287(1\u20132):179\u2013186","journal-title":"J Immunol Methods"},{"issue":"7","key":"1219_CR21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2174\/138920207783591690","volume":"8","author":"SCL Gough","year":"2007","unstructured":"Gough SCL, Simmonds MJ (2007) The HLA region and autoimmune disease: associations and mechanisms. Curr Genomics 8(7):453\u2013465","journal-title":"Curr Genomics"},{"issue":"5","key":"1219_CR22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/bfgp\/elr023","volume":"10","author":"MA Brown","year":"2011","unstructured":"Brown MA (2011) Progress in the genetics of ankylosing spondylitis. Brief Funct Genomics 10(5):249\u2013257","journal-title":"Brief Funct Genomics"},{"issue":"4","key":"1219_CR23","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/rheumatology\/kep450","volume":"49","author":"NJ Sheehan","year":"2010","unstructured":"Sheehan NJ (2010) HLA-B27: what\u2019s new? Rheumatology (Oxford) 49(4):621\u2013631","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"1219_CR24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0192-0561(88)90124-5","volume":"10","author":"PO Ogunbiyi","year":"1988","unstructured":"Ogunbiyi PO, Conlon PD, Black WD, Eyre P (1988) Levamisole-induced attenuation of alveolar macrophage dysfunction in respiratory virus-infected calves. Int J Immunopharmacol 10(4):377\u2013385","journal-title":"Int J Immunopharmacol"},{"issue":"3","key":"1219_CR25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4065\/84.3.255","volume":"84","author":"DJ Alfandre","year":"2009","unstructured":"Alfandre DJ (2009) I\u2019m going home: discharges against medical advice. Mayo Clin Proc 84(3):225\u2013260","journal-title":"Mayo Clin Proc"},{"key":"1219_CR26","doi-asserted-by":"crossref","unstructured":"Green EC, Murphy E (2014) Health Belief Model. The Wiley Blackwell Encyclopedia of Health, Illness, Behavior and Society, pp 766\u2013769","DOI":"10.1002\/9781118410868.wbehibs410"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-015-1219-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T10:25:19Z","timestamp":1599128719000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1756-0500\/8\/240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,13]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1219"],"URL":"https:\/\/doi.org\/10.1186\/s13104-015-1219-4","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,13]]},"article-number":"240"}}